Heydoc secures $8.3m Series A led by Smedvig Capital to accelerate growth
Heydoc, an integrated clinical operating system and electronic health record (EHR), today announced it has closed a $8.3m Series A round led by Smedvig Capital with existing investors Hambro Perks, Triple Point Ventures and InHealth Ventures also participating. This brings the total amount raised to date by Heydoc to $12m.
The new funding will be used for further expansion in the UK healthcare market, where Heydoc is rapidly growing, and to expand its product offering to its existing and new clients. The raise will also allow Heydoc to expand internationally beyond their current nascent international footprint. The bulk of the raise will be used to grow the team which currently stands at 30 employees.
Heydoc’s mission is to improve healthcare by empowering clinical teams with an all-encompassing operating system. Their innovative, user friendly software solves core workflow issues for clinicians, transforming both the user and patient experience and providing a vastly improved offering compared to existing legacy solutions. The system provides a full suite of features for clinicians and support staff, covering both medical and administrative tasks. Heydoc also connects its clinic customers with various other healthcare providers (e.g., hospital groups, pathology services, pharmacies, etc.), ensuring data liquidity and tackling a major challenge in healthcare, the lack of systems interoperability.
Since going live in 2018, Heydoc, co-founded by serial entrepreneurs Christoph Lippuner and Mikael Landau, has been working with clinical teams to consistently improve the quality of their care delivery. Over the past 18 months Heydoc has accelerated rapidly, helping clinics to embrace remote consultations throughout the pandemic and capitalising on a broader switch to cloud-based workflow systems. They have gained rapid traction through word-of-mouth referrals and now serve thousands of clinicians and administrative staff across the UK.
Christoph Lippuner, Co-Founder & CEO at Heydoc, commented: “We’re very excited to have Smedvig Capital as a partner in this new chapter of our adventure. This new raise will help us accelerate our growth in the UK, focus on our product and expand its capabilities, as well as go after international markets. Innovating and contributing to a transforming healthcare industry, profoundly impacted by regulatory changes, new patient expectations and a global pandemic, is both fascinating and rewarding. There is so much to be done in this industry and Heydoc is barely scratching the surface.”
Jon Lerner, Managing Director at Smedvig Capital, added: “We are delighted to invest in Heydoc and partner with Christoph and Mikael. Heydoc has grown rapidly and proven that its platform can dramatically improve the way clinicians work and the quality of patient interaction. The company has a strong mission-based culture and a huge opportunity in front of them to be part of the future of healthcare. We’re looking forward to supporting them in achieving this goal.”